5[1]Bates DW,Cullen D,Laird N,et al.Incidence of adverse drug event and potential adverse drug events:implication for prevention.JAMA,1995,274:29-34
6[2]Bates DW,Miller EB,Cullen DJ,et al.Patient risk factors for adverse drug events in hospitalized patients.Arch Intern Med,1999,159:2553-2560
7[3]Gurwitz JH,Field TS,Harrold LR,et al.Incidence and preventability of adverse drug events among older persons in the ambulatory setting.JAMA,2003,289:1107-1116
8[4]Naranjo CA,Busto U,Sellers EM,et al.A reliable method for estimating the probability of adverse drug reactions.Clin Phar Ther,1981,30:239-245
9[5]Schumock GT,Thoroton JP.Focusing on preventability of adverse drug reactions.Hosp Pharm,1992,27:538
10[6]Johnson JM,Tanner LA.Postmarketing surveillance:curriculum for the clinical pharmacologist,Part Ⅱ:Clinical and regulatory considerations.J Clin Pharmacol,1993,33:1015-1022
